(PKTX)...Protokinetix's Scientific Research..Cells are the basic independent units of life. Cell clusters that perform similar functions are tissues and organs. Cell function and survival is constantly challenged as cells, and tissues and organs, are subjected to a multitude of environmental stresses, aging, various diseases and genetic disorders.
Cell therapy is a field of medicine that uses cells to repair tissues and organs that have been damaged by human disease or to generate new tissues with desired functional activities. Medical science is making considerable progress in research and developing therapies using embryonic and adult stem cells.
At the same time the use of blood component cells in transfusions and organ transplants continue to be an important part of many medical treatments. Cells, tissues and organs all need to survive with enhanced health for these procedures to be more effective.
ProtoKinetix’ anti-aging glycopeptides, trademarked as AAGPs™, have demonstrated in tests the ability to enhance the health and extend the life of biologically sensitive cells which have been subjected to acute stress conditions under laboratory controlled protocols. AAGPs™ have shown to be stable and non-toxic.
ProtoKinetix owns the world-wide rights to this family of anti-aging glycopeptides.
Since inception in 2004, ProtoKinetix has primarily focused on scientific research, but the company is now in the process of directing major efforts to the practical side of commercialization. The commercial applications for AAGPs™ in large markets such as skincare/cosmetic products and targeted health care solutions are numerous. ProtoKinetix is currently working with leading businesses to bring AAGP™ to market.
Posted by T e x on :